Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Need PR coverage on Patient- 21 months insulin independent

<< Previous

Bullboard Posts

Next >>

Comment by Ekenbulletson Jan 11, 2022 4:34am

227 Views

Post# 34302521

RE:Need PR coverage on Patient- 21 months insulin independent

Its not interesting at this point, no news outlet will pick this up so soon after Vertex took the space. I told long ago that Sernova should communicate a user perspective with testamonial from the first patient. They missed the opportunity to free world wide coverage worth millions. The Vertex news exploded in the diabetes communties around the world, it was also posted uncountable times in so many facebook groups. In those groups you find all kinds of business leaders and investors. Sernovas news yesterday is sadly yesterdays news for the general public. Such a missed opportunity, a real amateur show.

<< Previous

Bullboard Posts

Next >>

High Tide adds two stores to undervalued cannabis retail network